New Healthcare AI Play: AI (CSE: TRUE)

NIA has discovered a new healthcare AI play with huge potential AI (CSE: TRUE).

NIA's first healthcare AI stock suggestion Healwell AI (TSX: AIDX) increased from our suggestion price of $0.95 per share up to a high so far of $1.93 per share for a gain of 103.16% in six weeks.

The new CEO of TRUE is Essam Hamza who joined the company in October 2023 after previously founding CloudMD. As CEO of CloudMD from 2019 through 2022, he increased CloudMD's revenue from $4 million up to over $100 million. Between December 2019 and October 2020, CloudMD increased from $0.275 per share up to a high of $3.43 per share for a gain of 1,147.27% in ten months. In October 2020, CloudMD traded 68.437 million shares in a single month.

TRUE has only 39,223,518 shares outstanding for a low market cap at $0.71 per share of only CAD$27.849 million or USD$20.3 million.

TRUE has developed the world’s most intelligent, personalized healthcare AI engine, the Global Library of Medicine. It is growing rapidly and currently comprises 1,000 of the most common clinically seen illnesses and over 10,000 symptoms and risk factors. TRUE's AI platform is so accurate that a non-medical student using TRUE's medical diagnostic software for the OSCE exam achieved a 92% success rate.

TRUE has partnered with both the Mayo Clinic and the University of Minnesota, and its AI platform is being used to train medical students and help make quick, accurate diagnoses in hospitals. TRUE is currently in discussions with 52 additional organizations including 27 medical schools. TRUE's Medical Education Suite provides case-based clinical decision-making testing, grading and remedial action support for the next generation of healthcare professionals.

One billion people ask Google about health concerns daily and often receive inaccurate information. Other large language models (LLMs), such as ChatGPT, do not provide accurate or reliable information.

TRUE's healthcare AI engine streamlines administrative duties helping eliminate the 15-30% of healthcare spending that goes towards administrative waste. It offers recommendations and double checks work and treatments, by providing explanations of every step and likelihood associated with various symptoms. It recommends appropriate tests and physical exams to support the accuracy of a diagnosis.

TRUE's underlying software is also the foundation of new products that the company is planning to launch in the healthcare marketplace later this year to dramatically disrupt how healthcare is delivered worldwide. Last week alone, TRUE added two new solutions to its Medical Education Suite: 1) AI Patient and 2) AI Doctor in a Pocket.

TRUE has a very bullish chart and is slowly trending upward on volume that is steadily increasing.

TRUE has a U.S. OTCQB symbol TREIF.

Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from AIDX of US$50,000 cash for a six-month marketing contract. NIA has received compensation from TRUE of US$50,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.